in developing countries. Cardiac complications often accompany poisoning with these compounds, which are potentially preventable if they are recognized early and treated adequately.
myocyte injury and loss of sarcolemmal integrity (Green et al., 2008) . They were considered important tools for diagnosis, risk assessment and therapeutic decision making in cardiovascular diseases (Felker et al., 2009 ).
Brain natriuretic peptide (BNP) and its N-terminal fragment originate from a prohormone precursor molecule that is called "proBNP". It is released by the ventricular wall in response to myocyte stretch or stress due to inflammation and hypoxia. Once "proBNP" is released into the circulation, it is cleaved into "BNP" and "NT-proBNP" with a half-life ranging from 20 minutes and 90-120 minutes respectively (DeFilippi et al., 2008) . Minimal elevations of NT-pro BNP in asymptomatic patients are highly predictive of future cardiac events including mortality (Belagaviet al.,2012) .
New prospective studies that compare BNP/NT -pro BNP assays with wellestablished markers of cardio toxicity, such as creatine kinase-myocardial band (CK-MB)and Troponins are needed (O'Brien, 2008) .The purpose of the present study was to investigate the potential benefit of NT-pro BNP as an early marker of cardio toxicity induced by acute OP poisoning and to compare the beneficial value of plasma NT-pro BNP with the wellassessed cardiac markers as CK-MB and Troponin I (cTnI).
Myocardial injury is a strong predictor of death in patients with OP poisoning (Aghabiklooei et al., 2013) . The cardiac toxicity associated with OP poisoning is caused by sympathetic and parasympathetic over-activity, hypoxemia, metabolic acidosis, electrolyte derangements, lipid per oxidation of myocardium with oxidative stress, healing mechanisms of the damaged myocardium and a direct toxic effect of OPC on the myocardium (Kose et al., 2009 ).
The manifestations of cardiac injury may remain subclinical and masked with OP symptoms. It may be represented by cardiac arrhythmias and myocardial infarction (Vijayakumar et al., 2011) .Cardiac injury may be serious and often fatal. Hence, early detection is crucial for applying preventive and supportive therapeutic strategies (Horacek et al., 2014) .
Currently, the diagnosis of cardio toxicity is based mainly on changes in electrocardiography(ECG) and increased release of cardiac biochemical markers. However, definite myocardial injury is difficult to assess through ECG and in most patients, the initial ECG is non-diagnostic while the heart is suffering in a silent way (Cha et al., 2014) .
All cardiac biomarkers are macromolecules found in cardiac myocytes and their appearance in the serum is indicative of Mansoura J. Forensic Med. Clin. Toxicol.
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The diagnosis of acute OP poisoning based on toxic exposure to an OPC within 6 hours, as evidenced by history, physical examination and PCE level. The primary diagnosis of cardio toxicity based on the presence of hemodynamic instability and/ or ECG abnormalities.
All patients were subjected to full history taking with special regard to demographic data, circumstances of exposure, OPC consumed, time elapsed between exposure and admission to hospital and any underlying diseases. Vital signs, gastrointestinal, respiratory and cardiovascular systems were assessed on admission.
Exclusion criteria
•All patients admitted to hospital more than six hours from exposure or had ingested other substances in addition to OPC.
• Patients with a history of cardiac disease, skeletal muscle trauma or disease, malignancy, patients on chemotherapy and patients older than 50 years.
• Patients with chronic malnutrition, liver damage and pregnant females.
• Patients on drugs that cause changes in heart rate or rhythm (bronchodilators, antidepressants, antipsychotics and anticholinergics).
Sampling
Eight milliliters venous blood sample was obtained under complete aseptic tech-
SUBJECTS AND METHODS
This randomized prospective comparative study got the approval of the local Research Ethical Committee. Informed consents were obtained from the studied individuals or persons on his/her behalf for participation in this study. Patients included in the study were treated according to the standard management guidelines of OP poisoning.
Subjects:
This study was conducted on 150 individuals of both sexes, 100 of them are acute OP poisoned cases, presented within 6 hours from exposure to the Toxicology Unit of Emergency Hospital of Mansoura University and the remaining 50 subjects are healthy individuals as a control group. This study was carried out during the period from the beginning of June 2012 to the end of June 2014. Participantswere divided into three groups:
Group I (control group): For laboratory evaluation of the baseline levels of pseudocholinesterase (PCE) and other studied cardiac biomarkers.
Group II: Included 38 OP poisoned patients without cardio toxic manifestations.
Group III: Included 62 OP poisoned patients with cardio toxic manifestations.
Mann-Whitney and Wilcoxon tests were used for comparison between twoOP poisoning groups (II and III), while Kruskal Wallis and multiple comparisons Dunn's post-tests were used for multiple groups comparisons. Fisher exact test and chisquare tests were used to study associations. For correlation, spearman rank correlation test was considered. Normally distributed variables were presented as mean ± standard deviation (SD). P value was considered significant at values ≤0.05.
RESULTS
In the present study, the number of studied population consisted of 150 subjects (67 males and 83 females) with age ranged from 6 to 50 years with a mean of age 35.3 ± 11.5 years. Fifty-nine percent of the studied OP poisoned cases were from rural areas and farmers represent 26 % of OP poisoned cases. (1),sinus tachycardia appeared to be a more prominent cardiac sign (32.2 %) than sinus bradycardia (27.4%) among group III. Hypotension and hypertension developed with the same percentage (16%) in cases with cardiac signs. Thirty percent of cases presented with subnormal temperature. There were significant differences between cases with and without cardiac signs regarding pulse, blood pressure and axillary body temperature. nique; two milliliters were put in ethylene diamine tetra-acetic acid (EDTA) tube for determination of plasma NT-pro BNP and six milliliters in plain tube for determination of serum PCE, CK-MB and cTnI. Samples were centrifuged within 30 min of collection. The supernatant of plasma and sera were collected in labeled sterile containers and kept frozen at -70°C until analysis except for PCE and CK-MB that were done sequentially.
As shown in table

Methods
• Measurement of PCE in the serum was done by spectrophotometer using Quimica Clinica Aplicada S.A. kits.
• Measurement of serum CK-MB was done by the Immune-Inhibition International Federation of Clinical Chemistry Method using ELI Tech clinical systems kits.
• Measurement of serum cTnI was done by the electrochemical-luminescence immunoassay "ECLIA" analyzers using Troponin I Short Turnaround Time kits.
• Measurement of plasma NT-pro BNP was done by spectrophotometer using "Sun Red human NT-pro BNP enzymelinked immune sorbent assay (ELISA) kits".
Statistical Analysis
All statistical procedures were performed using PRISM 5 (Graph Pad Software Inc., San Diego, CA). As data showed non-parametric distributions,
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(38.7%) were the most common ECG changes.
Regarding cardiac markers among studied cases, there was significant difference between control group and OP poisoned groups (II and III) regarding plasma NT-pro BNP levels on admission with no significant difference regarding serum CK-MB and Troponin I levels as shown in table (3).
According to Paradeniya Organophosphorus Poisoning (POP) scale of severity, there was significant difference between cases with and without cardiac signs regarding severity of poisoning as shown in table (2).
Out of 100 OP poisoned cases, 62% of cases showed abnormalities in ECG waves in the 1 st six hours of exposure. Increased corrected QT (QTc)interval (71%), T wave inversion (45%) and ST wave elevation On the other hand, there was significant difference between OP poisoned cases group II versus group III regarding plasma NT-pro BNP levels on admission with no significant differences regarding serum CK-MB and Troponin I levels as shown in table (4). Moreover, plasma NT-pro BNP was elevated above normal in 60.5% of Regarding POP scale of severity and peripheral cholinergic manifestations, there were statistically significant differences between OP poisoned cases in groups II and III. Similar results were previously reported by Siegal et al. (2009) . Also Rehiman et al. (2008) stated that with increasing the severity of poisoning, the incidence of cardiac manifestations increased. On the other hand, 14.5% of OP poisoned cases exhibited cardiac signs although they were presented with mild manifestation. This can be explained by the fact that myocardial involvement from direct cardiac toxicity is patchy that may not manifest clinically while the heart is suffering in a silent way (Anand et al., 2009) .
The most common ECG changes in this study were increased QTc interval, T wave inversion and ST wave elevation. Similar observations were reported by Yurumez et al. (2009) and Vijayakumar et al. (2011) . ECG abnormalities often accompany poisoning with OPC but their exact nature is not fully understood. Bizarre cardiac abnormalities can occur in the form of tachycardia, bradycardia and prolonged QTc and PR intervals, depending on whether nicotinic or muscarinic effect pre-
DISCUSSION
The present work was carried out to assess the potential benefit of NT-pro BNP as an early marker of cardio toxicity induced by acute OP poisoning and to compare its beneficial value with the well assessed cardiac markers CK-MB and cTnI. There were statistically significant differences between cases of group II and III regarding their pulse, blood pressure and axillary temperature. Sinus tachycardia appeared to be a more prominent presentation than sinus bradycardia in OP poisoned cases with cardiac signs. Hypertension and hypotension developed with the same incidence and percentage in OP poisoned cases with cardiac signs, although none of them had previous history of blood pressure disorders. Agarwal et al. (2007) found that the nicotinic manifestations such as tachycardia and hypertension are the most common cardiac signs on presentation. Some investigators considered the presence of hypertension and sinus tachycardia as manifestations of severe OP poisoning (Karki et al., 2004) .
On the other hand, hypotension may occur secondary to augmented vagal tone with muscarinic over stimulation and/or stimulation of vascular receptors by excessive circulating acetylcholine causing peripheral vasodilatation (Davies et al., 2008) . As regard axillary temperature, 30% of OP poisoned cases presented with sub-ml and in (60.5%) of OP poisoning without cardiac signs from which (15.8%) were > 450 pg/ml within the 1 st six hours from exposure. Only plasma levels of NT-pro BNP showed highly significant differences among cases of OP poisoning with and without cardiac signs on admission.
This indicates that NT-pro BNP is an early specific marker for cardiac stress that may occur early within the 1 st six hours in OP poisoning than CK-MB or Troponin I. Moreover, its elevation in cases without cardiac signs reflected its value in detecting silent myocardial suffering during the acute OP poisoning. DeFilippi et al. (2008) stated that, whenever there is myocardial stress causing myocyte stretch, there will be active secretion of NT-pro BNP. Measurements of NT-pro BNP may be more effective for monitoring poisoninduced left ventricular dysfunction and early detection of myocardial stress (O'Brien, 2008) .
This was accepted by Costello-Boerrigter et al. (2006) and Porapakkham et al. (2010) who stated that NT-pro BNP is a sensitive marker for cardiac dysfunction. An elevated NT-pro BNP level always indicates the presence of an underlying cardiac disorder and levels correlate directly with the severity of disorder. On the other hand, a normal NT-pro BNP level virtually excludes cardiac dysfunction.
dominates (Siegal et al., 2009 ). These ECG abnormalities may be serious and often fatal (Bar-Meir et al., 2007) .
In the present study, the mean levels of CK-MB and cTnI were more elevated in cases of group III than group II on admission with no statistically significant differences between both groups. Similar results were previously reported by Yavuz et al. (2008 ), Wan et al. (2012 and Aghabiklooei et al. (2013) .
Although elevation of serum CK-MB is a specific marker of acute myocardial infarction, Troponin I is more specific than CK-MB for myocardial injury because it is expressed only in cardiac muscle and has high sensitivity in detection of even small amounts of myocardial necrosis even before impairment of cardiac function. The magnitude of increase in serum Troponins correlates with the extent of myocardial injury (Thygesen et al., 2012) .
Measurement of NT-pro BNP represents an interesting strategy for detecting subclinical cardio toxicity and reflects the hemodynamic status of the heart (Zidan et al., 2015) . Jankowski (2008) and Felker et al. (2009) reported that if NT-pro BNP is elevated > 450 pg/ml in patients < 50 years, heart failure is likely. In this study NT-Pro BNP was significantly higher in all OP poisoned cases with cardiac signs (100%) from which (26%) were > 450 pg/ Mansoura J. Forensic Med. Clin. Toxicol. 
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CONCLUSION
From the current work, it can be concluded that NT-pro BNP can be used as a significant diagnostic screening tool for silent myocardial suffering and stress that may occur early during the course of acute OP poisoning than cTnI and CK-MB, allowing for early specific cardio-protective therapies. Mansoura J. Forensic Med. Clin. Toxicol. 
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